Compositions and methods for enhancing ion transporter activity and uses thereof

Methods for enhancing the activity of an ion transporter in a cell and/or treating a channelopathy in a subject based on the administration or use of an effective amount of a fenretinide compound (fenretinide, a fenretinide analog, or a pharmaceutically acceptable salt thereof) and/or zinc are descr...

Full description

Saved in:
Bibliographic Details
Main Authors HANRAHAN John, RADZIOCH Danuta, GARIC Dusan, ABU-ARISH Asmahan
Format Patent
LanguageEnglish
Hebrew
Published 30.11.2020
Online AccessGet full text

Cover

More Information
Summary:Methods for enhancing the activity of an ion transporter in a cell and/or treating a channelopathy in a subject based on the administration or use of an effective amount of a fenretinide compound (fenretinide, a fenretinide analog, or a pharmaceutically acceptable salt thereof) and/or zinc are described. The methods are useful for restoring or increasing the cell surface expression of an ion transporter such as the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) that is mutated or defective. The fenretinide compound and/or zinc may be used in combination with ion transporter modulators, e.g., CFTR modulators, to further enhance the cell surface expression and activity of the ion transporter.
Bibliography:Application Number: IL20200277964